Other studies have also supported the favourable prognostic role of HER4 in breast cancer both at the mRNA and the protein level (Pawlowski et al, 2000; Suo et al, 2002; Witton et al, 2003). The gene discussed is ERBB4; the disease is breast carcinoma.